Correction of Psoriatic T Cell Signatures by Deucravacitinib
Clinical trial NCT05858645 · RECRUITING
Trial details
- NCT number
- NCT05858645
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2028-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.